A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings

@article{Savard2012ACF,
  title={A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings},
  author={Patrice Savard and Trish M. Perl},
  journal={Current Opinion in Infectious Diseases},
  year={2012},
  volume={25},
  pages={371–377}
}
  • P. SavardT. Perl
  • Published 1 August 2012
  • Medicine, Biology
  • Current Opinion in Infectious Diseases
Purpose of review Multidrug-resistant (MDR) Enterobacteriaceae are an emerging and a major concern for the medical community. Reported rates of MDR Enterobacteriaceae are increasing, and infections with these organisms are no longer limited to those associated with healthcare in the severely ill or infirm. Community-acquired infections are now described. The purpose of this review is to provide the readers with an up to date picture of MDR Enterobacteriaceae and to highlight the infection… 

Multidrug and Cross-resistance Pattern of ESBL-producing Enterobacteriaceae Agents of Nosocomial Infections in Intensive Care Units

Background and purpose: Multiple drug resistance in Enterobacteriaceae has restricted the available options for treatment of infections caused by these bacteria. The aim of this study was to

Carbapenem Resistance In Enterobacteriaceae

Risk factors were found to be associated with increased susceptibility to develop carbapenem resiatance that should be searched for to prevent further spread of resistance.

Carbapenemase-producing Bacteria in Patients Hospitalized Abroad, France

A 33-month survey at Hopital Europeen Georges Pompidou of CPE and GRE in repatriated patients and clinical and laboratory data on 33 patients hospitalized in France who were previously hospitalized in other countries and were carrying carbapenemase-producing bacteria, glycopeptide-resistant enterococci, or both.

Prevalence of Multidrug-resistant and Carbapenemase-producing Klebsiella Pneumoniae and Pseudomonas Aeruginosa Isolates in Tertiary Care Hospital in Kathmandu, Nepal

The higher prevalence of MDR among K. pneumoniae and P. aeruginosa was determined, however, carbapenemase production was relatively low.

Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan

The prevalence of ESBL-producing Enterobacteriaceae is high in Pakistan and surveillance to better understand the annual ESBL burden is crucial to improve national and regional guidelines.

Rapid Detection of Carbapenemase Genes (Bla-Vim And Bla-Imp) By Multiplex Pcr in Gram-Negative Clinical Isolates

This study determined the higher prevalence of MDR and carbapenem resistance among Enterobacteriaceae, P. aeruginosa and A. baumannii as detected by the presence of bla-VIM andBla-IMP genes.

Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae

Bundles implemented in phases would seem to indicate that active surveillance cultures and the subsequent cohorting of patients and staff based on these results might be particularly beneficial for controlling horizontal transmission.

Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America.

...

References

SHOWING 1-10 OF 51 REFERENCES

How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies

Since it has been observed that lack of adequate and timely reaction is common and associated with great morbidity and mortality, preparation plans should be evaluated and implemented locally, regionally, nationally and even on an international level.

Status report on carbapenemases: challenges and prospects

This article focuses on the epidemiology of carbapenemase-producing Gram-negative bacteria and reviews available agents and those in development with potential activity against this evolving threat.

Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Exposure network analysis and molecular epidemiologic methods were used to analyze the emergence and regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae over a 1-year period and observed extensive transfer of KPC-positive patients throughout the exposure network of 14 acute care hospitals, 2 LTACHs, and 10 nursing homes.

Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010.

  • Medicine, Biology
    MMWR. Morbidity and mortality weekly report
  • 2010
During January-June 2010, three Enterobacteriaceae isolates carrying a newly described resistance mechanism, the New Delhi metallo-beta-lactamase (NDM-1), were identified from three U.S. states at

IMP-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States

Three carbapenem-resistant K. pneumoniae isolates recovered from pediatric patients at a single U.S. health care facility confirmed that these isolates produce IMP-4, an MBL carbapanemase not previously published as present among Enterobacteriaceae in the United States.

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

  • A. MagiorakosA. Srinivasan D. Monnet
  • Medicine, Biology
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012
A group of international experts came together through a joint initiative by the European Centre for Disease Prevention and Control and the Centers for Disease Control and Prevention, to create a standardized international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp.

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

The current epidemiology of CRE in the United States is described, including New Delhi metallo-β-lactamase, which highlights important prevention strategies.

The challenges of antimicrobial drug resistance in Greece.

  • S. MiyakisA. PefanisA. Tsakris
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2011
Antimicrobial drug resistance rates in Greece are among the highest in Europe. The prevalence of carbapenem-resistant Gram-negative species has increased considerably, including endemic strains in

Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

The Gram-Negative Resistance Summit convened national opinion leaders for the purpose of analyzing current literature, epidemiologic trends, clinical trial data, therapeutic options, and treatment guidelines related to the management of antibiotic-resistant GNB infections.
...